CN Stock MarketDetailed Quotes

Hebei Changshan Biochemical Pharmaceutical (300255)

Watchlist
  • 40.41
  • -0.59-1.44%
Market Closed May 20 15:00 CST
37.14BMarket Cap-104.42P/E (TTM)

Hebei Changshan Biochemical Pharmaceutical (300255) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Low molecular weight heparin preparation361.69M41.33%
Common heparin drug173.79M19.86%
Low molecular weight heparin drug159.91M18.27%
Other122.05M13.95%
Ordinary heparin preparation57.69M6.59%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Biological medicine753.08M86.05%
Other122.05M13.95%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Domestic683.16M78.06%
Abroad191.97M21.94%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 19, Eastern Time, Trump issued a clear countdown: 'in two or three days—maybe Friday, Saturday, Sunday, or early next week'—the U.S. Show More